Middle East & Africa Lung Cancer Screening Software Market to 2032
Overview
The Middle East & Africa Lung Cancer Screening Software Market is expected to reach a 1.27 USD Million by 2032 and is projected to grow at a CAGR of 26.85% from 2025 to 2032.
Revenue, 2024 (USD Million)
0.42
Forecast, 2032 (USD Million)
1.27
CAGR, 2024 - 2032
26.85%
Report Coverage
Middle East & Africa
Middle East & Africa Lung Cancer Screening Software Market 2018-2032 USD Million
Middle East & Africa Lung Cancer Screening Software Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 0.42 USD Million
- Projected Market Size (2032): 1.27 USD Million
- CAGR (2025-2032): 26.85%
Key Findings of Middle East & Africa Lung Cancer Screening Software Market
- The Middle East & Africa Lung Cancer Screening Software Market was valued at 0.42 USD Million in 2024.
- The Middle East & Africa Lung Cancer Screening Software Market is likely to grow at a CAGR of 26.85% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Institutional in Purchase Mode Segment accounted for the largest share of the market with a revenue of 0.33 USD Million
- The fastest growing segment Nodule Management Software in Product Segment grew Fastest with a CAGR of 30.09% during the forecast period from 2024 to 2032.
Middle East & Africa Lung Cancer Screening Software Market Scope
Middle East & Africa Lung Cancer Screening Software Market Segmentation & Scope
Application
- Small Cell Lung Cancer (SCLC)
- Non-Small Cell Lung Cancer (NSCLC)
Platform
- Integrated
- Standalone
Purchase Mode
- Individual
- Institutional
End User
- Others
- Ambulatory Surgical Centers
- Hospitals
- Oncology Centers
Product
- Audit Log Tracking
- Practice Management
- Screening PACs
- Statistical Audit Reporting
- Pathology and Cancer Staging
- Lung Nodule Computer Aided Detection
- Patient Coordination and Workflow
- Data Collection and Reporting
- Nodule Management Software
- Lung Cancer Screening Patient Management Software
- Lung Cancer Screening Radiology Solution
Type
- Traditional Screening
- Computer-Assisted Screening
Distribution Channel
- Third Party Distributor
- Direct Tenders
Mode of Delivery
- Web Based Solutions1
- On-Premise Solutions1
- Cloud Based Solutions1
Middle East & Africa Lung Cancer Screening Software Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 0.42 USD Million |
| Market Value in 2032 | 1.27 USD Million |
| CAGR (2025-2032) | 26.85% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,Platform,Purchase Mode,End User,Product,Type,Distribution Channel,Mode of Delivery |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 0.42 USD Million in 2024
- Key Country: Saudi Arabia, leading in terms of revenue with value of 0.16 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Lung Cancer Screening Software Market to 2032, By Application
- Non-Small Cell Lung Cancer (NSCLC) is the largest segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a revenue of 0.31 USD Million in the year 2024.
- Non-Small Cell Lung Cancer (NSCLC) is the Fastest growing segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a Growth rate of 28.24 % in forecast period 2025-2032.
-
Middle East & Africa Lung Cancer Screening Software Market to 2032, By Platform
- Standalone is the largest segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a revenue of 0.27 USD Million in the year 2024.
- Integrated is the Fastest growing segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a Growth rate of 25.58 % in forecast period 2025-2032.
-
Middle East & Africa Lung Cancer Screening Software Market to 2032, By Purchase Mode
- Institutional is the largest segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a revenue of 0.33 USD Million in the year 2024.
- Institutional is the Fastest growing segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a Growth rate of 27.82 % in forecast period 2025-2032.
-
Middle East & Africa Lung Cancer Screening Software Market to 2032, By End User
- Oncology Centers is the largest segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a revenue of 0.29 USD Million in the year 2024.
- Oncology Centers is the Fastest growing segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a Growth rate of 29.01 % in forecast period 2025-2032.
-
Middle East & Africa Lung Cancer Screening Software Market to 2032, By Product
- Lung Cancer Screening Radiology Solution is the largest segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a revenue of 0.14 USD Million in the year 2024.
- Nodule Management Software is the Fastest growing segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a Growth rate of 26.38 % in forecast period 2025-2032.
-
Middle East & Africa Lung Cancer Screening Software Market to 2032, By Type
- Computer-Assisted Screening is the largest segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a revenue of 0.31 USD Million in the year 2024.
- Computer-Assisted Screening is the Fastest growing segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a Growth rate of 28.18 % in forecast period 2025-2032.
-
Middle East & Africa Lung Cancer Screening Software Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a revenue of 0.29 USD Million in the year 2024.
- Direct Tenders is the Fastest growing segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a Growth rate of 28.54 % in forecast period 2025-2032.
-
Middle East & Africa Lung Cancer Screening Software Market to 2032, By Mode of Delivery
- Cloud Based Solutions1 is the largest segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a revenue of 0.20 USD Million in the year 2024.
- Web Based Solutions1 is the Fastest growing segment in Middle East & Africa Lung Cancer Screening Software Market to 2032 with a Growth rate of 27.95 % in forecast period 2025-2032.
Middle East & Africa Lung Cancer Screening Software Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Oncocyte Corporation | |||
| Nuance Communications, Inc. | |||
| Koninklijke Philips N.V. | |||
| Thynk Health | |||
Middle East & Africa Lung Cancer Screening Software Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Lung Cancer Screening Software Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Lung Cancer Screening Software Market is segmented based on Segmentation Application,Platform,Purchase Mode,End User,Product,Type,Distribution Channel,Mode of Delivery.
Middle East & Africa Lung Cancer Screening Software Market was valued at USD 0.42(Revenue in USD Million) in 2019.
Middle East & Africa Lung Cancer Screening Software Market is projected to grow at a CAGR of 26.85% during the forecast period of 2024 to 2032.
The Institutional segment is expected to dominate the Middle East & Africa Lung Cancer Screening Software Market, holding a largest market share of 0.33 USD Million in 2024
Middle East & Africa Lung Cancer Screening Software Market Scope
Middle East & Africa Lung Cancer Screening Software Market Segmentation & Scope
Application
- Small Cell Lung Cancer (SCLC)
- Non-Small Cell Lung Cancer (NSCLC)
Platform
- Integrated
- Standalone
Purchase Mode
- Individual
- Institutional
End User
- Others
- Ambulatory Surgical Centers
- Hospitals
- Oncology Centers
Product
- Audit Log Tracking
- Practice Management
- Screening PACs
- Statistical Audit Reporting
- Pathology and Cancer Staging
- Lung Nodule Computer Aided Detection
- Patient Coordination and Workflow
- Data Collection and Reporting
- Nodule Management Software
- Lung Cancer Screening Patient Management Software
- Lung Cancer Screening Radiology Solution
Type
- Traditional Screening
- Computer-Assisted Screening
Distribution Channel
- Third Party Distributor
- Direct Tenders
Mode of Delivery
- Web Based Solutions1
- On-Premise Solutions1
- Cloud Based Solutions1
Frequently Asked Questions
The Middle East & Africa Lung Cancer Screening Software Market is segmented based on Segmentation Application,Platform,Purchase Mode,End User,Product,Type,Distribution Channel,Mode of Delivery.
Middle East & Africa Lung Cancer Screening Software Market was valued at USD 0.42(Revenue in USD Million) in 2019.
Middle East & Africa Lung Cancer Screening Software Market is projected to grow at a CAGR of 26.85% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Lung Cancer Screening Software Market for final year is USD 1.27 (USD Million).
Middle East & Africa Lung Cancer Screening Software Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Lung Cancer Screening Software Market is segmented based on Segmentation Application,Platform,Purchase Mode,End User,Product,Type,Distribution Channel,Mode of Delivery.
Middle East & Africa Lung Cancer Screening Software Market was valued at USD 0.42(Revenue in USD Million) in 2019.
Middle East & Africa Lung Cancer Screening Software Market is projected to grow at a CAGR of 26.85% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Lung Cancer Screening Software Market for final year is USD 1.27 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.